 Josiane Broussard
Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Deprivation | 10 | 2024 | 171 | 3.520 |
Why?
| | Circadian Rhythm | 11 | 2025 | 416 | 2.980 |
Why?
| | Sleep | 14 | 2025 | 689 | 2.900 |
Why?
| | Insulin Resistance | 16 | 2024 | 1168 | 2.840 |
Why?
| | Obesity | 12 | 2024 | 2885 | 1.760 |
Why?
| | Sleep Wake Disorders | 3 | 2024 | 255 | 1.400 |
Why?
| | Insulin | 16 | 2024 | 2330 | 1.280 |
Why?
| | Muscle, Skeletal | 4 | 2021 | 1644 | 0.950 |
Why?
| | Shift Work Schedule | 1 | 2025 | 10 | 0.940 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2015 | 160 | 0.930 |
Why?
| | Work Schedule Tolerance | 1 | 2025 | 43 | 0.920 |
Why?
| | Wakefulness | 1 | 2023 | 120 | 0.800 |
Why?
| | Lipids | 2 | 2024 | 628 | 0.790 |
Why?
| | Triglycerides | 1 | 2024 | 528 | 0.770 |
Why?
| | Dogs | 10 | 2020 | 385 | 0.760 |
Why?
| | Postpartum Period | 1 | 2024 | 331 | 0.730 |
Why?
| | Diet, High-Fat | 2 | 2020 | 239 | 0.720 |
Why?
| | Metabolic Diseases | 1 | 2022 | 104 | 0.700 |
Why?
| | Carnitine | 1 | 2021 | 76 | 0.690 |
Why?
| | Adipocytes | 2 | 2012 | 205 | 0.660 |
Why?
| | Glucose Clamp Technique | 8 | 2024 | 194 | 0.650 |
Why?
| | Hyperinsulinism | 3 | 2016 | 119 | 0.590 |
Why?
| | Insulin-Secreting Cells | 2 | 2020 | 367 | 0.570 |
Why?
| | Blood Pressure | 1 | 2025 | 1736 | 0.570 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2017 | 97 | 0.550 |
Why?
| | Chronobiology Disorders | 1 | 2016 | 13 | 0.520 |
Why?
| | Cross-Over Studies | 4 | 2025 | 521 | 0.520 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2016 | 37 | 0.500 |
Why?
| | Energy Metabolism | 3 | 2023 | 875 | 0.500 |
Why?
| | Ghrelin | 1 | 2015 | 32 | 0.490 |
Why?
| | Eating | 3 | 2022 | 372 | 0.470 |
Why?
| | Exercise | 2 | 2024 | 1934 | 0.440 |
Why?
| | Glucose Tolerance Test | 5 | 2021 | 355 | 0.420 |
Why?
| | Lipid Metabolism | 2 | 2021 | 503 | 0.410 |
Why?
| | Sphingolipids | 2 | 2024 | 72 | 0.390 |
Why?
| | Random Allocation | 3 | 2020 | 347 | 0.380 |
Why?
| | Heart Diseases | 1 | 2015 | 352 | 0.380 |
Why?
| | Health Status Disparities | 2 | 2024 | 256 | 0.330 |
Why?
| | Male | 21 | 2025 | 63759 | 0.330 |
Why?
| | Appetite | 2 | 2022 | 61 | 0.310 |
Why?
| | Adipose Tissue | 2 | 2024 | 594 | 0.300 |
Why?
| | Humans | 26 | 2025 | 129847 | 0.300 |
Why?
| | Energy Intake | 3 | 2022 | 462 | 0.290 |
Why?
| | Blood Glucose | 9 | 2023 | 2103 | 0.280 |
Why?
| | Dietary Fats | 3 | 2020 | 303 | 0.280 |
Why?
| | Feeding Behavior | 2 | 2025 | 626 | 0.270 |
Why?
| | Adult | 10 | 2025 | 35634 | 0.270 |
Why?
| | Oxidation-Reduction | 2 | 2021 | 1031 | 0.270 |
Why?
| | Animals | 14 | 2024 | 35409 | 0.260 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2024 | 2444 | 0.260 |
Why?
| | Glucose Intolerance | 2 | 2020 | 142 | 0.250 |
Why?
| | Postmenopause | 2 | 2024 | 349 | 0.240 |
Why?
| | Venoms | 2 | 2016 | 29 | 0.240 |
Why?
| | Lipolysis | 1 | 2024 | 41 | 0.230 |
Why?
| | Female | 12 | 2025 | 68829 | 0.210 |
Why?
| | Circadian Clocks | 1 | 2023 | 46 | 0.210 |
Why?
| | Portal Vein | 2 | 2014 | 108 | 0.200 |
Why?
| | Young Adult | 6 | 2025 | 12467 | 0.200 |
Why?
| | Fasting | 2 | 2022 | 268 | 0.200 |
Why?
| | Cardiovascular Diseases | 2 | 2025 | 2008 | 0.200 |
Why?
| | Hypoglycemic Agents | 3 | 2016 | 1221 | 0.190 |
Why?
| | Leptin | 2 | 2015 | 222 | 0.190 |
Why?
| | Homeostasis | 2 | 2023 | 605 | 0.190 |
Why?
| | Gastrointestinal Microbiome | 2 | 2021 | 641 | 0.180 |
Why?
| | Body Weight | 4 | 2022 | 947 | 0.180 |
Why?
| | Citric Acid Cycle | 1 | 2021 | 55 | 0.180 |
Why?
| | Subcellular Fractions | 1 | 2021 | 80 | 0.180 |
Why?
| | Peptides | 2 | 2016 | 926 | 0.160 |
Why?
| | Mitochondria, Muscle | 1 | 2021 | 111 | 0.160 |
Why?
| | Weight Loss | 1 | 2024 | 740 | 0.160 |
Why?
| | Meals | 1 | 2020 | 119 | 0.160 |
Why?
| | Diet | 2 | 2015 | 1212 | 0.140 |
Why?
| | Denervation | 2 | 2014 | 22 | 0.140 |
Why?
| | Norepinephrine | 2 | 2015 | 209 | 0.140 |
Why?
| | Methyl Ethers | 1 | 2016 | 12 | 0.130 |
Why?
| | Isoflurane | 1 | 2016 | 27 | 0.130 |
Why?
| | Body Mass Index | 1 | 2024 | 2274 | 0.130 |
Why?
| | Subcutaneous Fat | 1 | 2016 | 74 | 0.130 |
Why?
| | Middle Aged | 5 | 2024 | 31177 | 0.130 |
Why?
| | Time Factors | 5 | 2025 | 6550 | 0.120 |
Why?
| | Sex Characteristics | 1 | 2021 | 735 | 0.120 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2015 | 23 | 0.120 |
Why?
| | Hydrocortisone | 2 | 2015 | 306 | 0.120 |
Why?
| | Fish Oils | 1 | 2015 | 27 | 0.120 |
Why?
| | Biomarkers | 3 | 2015 | 3971 | 0.120 |
Why?
| | Abdominal Fat | 1 | 2015 | 40 | 0.120 |
Why?
| | Dysbiosis | 1 | 2016 | 170 | 0.120 |
Why?
| | Pregnancy | 2 | 2024 | 6423 | 0.120 |
Why?
| | Human Growth Hormone | 1 | 2015 | 45 | 0.110 |
Why?
| | Receptors, Glucagon | 1 | 2014 | 27 | 0.110 |
Why?
| | Healthy Volunteers | 1 | 2015 | 201 | 0.110 |
Why?
| | Intra-Abdominal Fat | 1 | 2014 | 88 | 0.110 |
Why?
| | Prediabetic State | 1 | 2016 | 244 | 0.100 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2015 | 385 | 0.100 |
Why?
| | Thinness | 1 | 2012 | 89 | 0.090 |
Why?
| | Up-Regulation | 1 | 2015 | 836 | 0.090 |
Why?
| | Polysomnography | 1 | 2012 | 178 | 0.090 |
Why?
| | Adolescent | 5 | 2024 | 20451 | 0.090 |
Why?
| | Hyperglycemia | 1 | 2014 | 327 | 0.090 |
Why?
| | Cohort Studies | 1 | 2021 | 5444 | 0.090 |
Why?
| | Hemodynamics | 1 | 2015 | 1094 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2012 | 434 | 0.080 |
Why?
| | Sympathetic Nervous System | 1 | 2010 | 174 | 0.080 |
Why?
| | Body Composition | 3 | 2020 | 649 | 0.080 |
Why?
| | Hypoglycemia | 1 | 2014 | 427 | 0.080 |
Why?
| | Glucose | 3 | 2023 | 1003 | 0.080 |
Why?
| | Incidence | 1 | 2015 | 2646 | 0.080 |
Why?
| | Disease Models, Animal | 2 | 2016 | 4077 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2016 | 0.070 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2012 | 279 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2015 | 3397 | 0.070 |
Why?
| | Signal Transduction | 2 | 2024 | 4935 | 0.060 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2025 | 103 | 0.060 |
Why?
| | Adipogenesis | 1 | 2024 | 51 | 0.060 |
Why?
| | Glycerol | 1 | 2024 | 92 | 0.060 |
Why?
| | Isoproterenol | 1 | 2024 | 116 | 0.060 |
Why?
| | Reaction Time | 1 | 2005 | 411 | 0.050 |
Why?
| | ARNTL Transcription Factors | 1 | 2023 | 17 | 0.050 |
Why?
| | Memory | 1 | 2005 | 241 | 0.050 |
Why?
| | Liver | 3 | 2016 | 1839 | 0.050 |
Why?
| | Nutritional Status | 1 | 2025 | 328 | 0.050 |
Why?
| | Fitness Trackers | 1 | 2020 | 9 | 0.040 |
Why?
| | Publications | 1 | 2021 | 41 | 0.040 |
Why?
| | Health | 1 | 2021 | 75 | 0.040 |
Why?
| | Disease | 1 | 2021 | 94 | 0.040 |
Why?
| | Actigraphy | 1 | 2020 | 98 | 0.040 |
Why?
| | Weight Gain | 1 | 2022 | 510 | 0.040 |
Why?
| | Gene Expression | 1 | 2023 | 1465 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1597 | 0.040 |
Why?
| | Data Collection | 1 | 2020 | 653 | 0.040 |
Why?
| | Anesthesia, Inhalation | 1 | 2016 | 8 | 0.030 |
Why?
| | Sleep Stages | 1 | 2016 | 45 | 0.030 |
Why?
| | Propofol | 1 | 2016 | 63 | 0.030 |
Why?
| | Overweight | 1 | 2020 | 531 | 0.030 |
Why?
| | Glucagon | 1 | 2016 | 105 | 0.030 |
Why?
| | Sympathectomy, Chemical | 1 | 2014 | 5 | 0.030 |
Why?
| | Omentum | 1 | 2014 | 10 | 0.030 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2014 | 13 | 0.030 |
Why?
| | Mental Health | 1 | 2021 | 691 | 0.030 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2014 | 71 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2014 | 134 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 2014 | 146 | 0.030 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2014 | 92 | 0.030 |
Why?
| | Catecholamines | 1 | 2014 | 96 | 0.030 |
Why?
| | Organ Size | 1 | 2014 | 456 | 0.030 |
Why?
| | Intestines | 1 | 2016 | 350 | 0.030 |
Why?
| | Epinephrine | 1 | 2014 | 141 | 0.030 |
Why?
| | Models, Animal | 1 | 2014 | 376 | 0.030 |
Why?
| | Risk Factors | 1 | 2024 | 9801 | 0.020 |
Why?
| | Infant | 1 | 2023 | 9018 | 0.020 |
Why?
| | Islets of Langerhans | 1 | 2014 | 791 | 0.020 |
Why?
| | United States | 1 | 2025 | 13913 | 0.020 |
Why?
| | Habituation, Psychophysiologic | 1 | 2005 | 53 | 0.020 |
Why?
| | Memory, Short-Term | 1 | 2005 | 258 | 0.010 |
Why?
| | Prospective Studies | 1 | 2012 | 7158 | 0.010 |
Why?
|
|
Broussard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|